Clinical Trials
14 trialsNCT06125951 2026-04-23
XanaMIA
Actinogen Medical
Phase 2/3 Active not recruiting
NCT07502118 2026-03-30
NexCAR19
Health Institutes of Turkey
Phase 2/3 Recruiting
NCT04345718 2025-12-09
EXHITENTRE
Hennepin Healthcare Research Institute
Phase 2/3 Completed
NCT04575064 2024-10-09
An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY
Klinikum Bremen-Mitte, gGmbH
Phase 2/3 Withdrawn
NCT00096460 2023-01-05
BMT CTN 0202
Medical College of Wisconsin
Phase 2/3 Terminated
NCT02793583 2022-07-21
UNITY-NHL
TG Therapeutics, Inc.
Phase 2/3 Terminated
NCT00003338 2021-08-16
Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma
Gilead Sciences
Phase 2/3 Unknown
NCT00003816 2021-08-13
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Roswell Park Cancer Institute
Phase 2/3 Completed
NCT04873414 2021-06-02
PlaSenTer
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
Phase 2/3 Unknown
NCT03262961 2017-08-28
Use of Sildenafil Citrate in Management of Mild Pre-eclampsia
Assiut University
Phase 2/3 Unknown
NCT02612415 2016-12-16
FIRST-ABC
Great Ormond Street Hospital for Children NHS Foundation Trust
Phase 2/3 Completed
NCT00147121 2016-09-22
Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)
Japan Clinical Oncology Group
Phase 2/3 Completed
NCT02072330 2014-02-26
Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.
Takeda
Phase 2/3 Completed
NCT00045877 2006-02-06
Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
Chiron Corporation
Phase 2/3 Completed